| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8447949 | European Journal of Cancer | 2010 | 9 Pages |
Abstract
HMGB1 protein may contribute to the malignant progression of SCCHN, and present as a novel prognostic marker and a potential therapeutic target for patients with SCCHN.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Yong Liu, Congliang Xie, Xin Zhang, Donghai Huang, Xiaojuan Zhou, Pingqing Tan, Lin Qi, Guoqing Hu, Yongquan Tian, Yuanzheng Qiu,